Ajanta Pharma Ltd Half Yearly Results

Gross Sales

2,316.54

2,331.56

2,159.23

2,049.48

1,853.61

Excise Duty

0

0

0

0

0

Net Sales

2,316.54

2,331.56

2,159.23

2,049.48

1,853.61

Other Operating Income

0

0

0

0

0

Other Income

48.55

45.95

41.51

43.09

25.53

Total Income

2,365.09

2,377.51

2,200.74

2,092.57

1,879.14

Total Expenditure

1,698.56

1,690.04

1,559.26

1,477.51

1,488.46

PBIDT

666.53

687.47

641.48

615.06

390.68

Interest

13.98

6.75

4.02

3.19

3.97

PBDT

652.55

680.72

637.46

611.87

386.71

Depreciation

75.75

68.36

68.51

66.89

66.32

Minority Interest Before NP

0

0

0

0

0

Tax

156.81

155.49

164.42

157.64

95.36

Deferred Tax

-38.15

-5.38

-8.22

-16.08

-31.73

Reported Profit After Tax

458.14

462.25

412.75

403.42

256.76

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

458.14

462.25

412.75

403.42

256.76

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

458.14

462.25

412.75

403.42

256.76

EPS (Unit Curr.)

36.26

36.88

32.67

32.04

20.32

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

1,400

0

0

0

Equity

25.07

25.07

25.27

25.27

25.27

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

28.77

29.48

29.7

30.01

21.07

PBDTM(%)

-

-

-

-

-

PATM(%)

19.77

19.82

19.11

19.68

13.85